Pain in femoral arteriography: A double-blind, randomized, clinical study                comparing safety and efficacy of the iso-osmolar iodixanol 270mgI/ml and the                low-osmolar iomeprol 300 mgI/ml in 9 European centers

Manke, C.; Marcus, C.; Page, Andrew C.; Puey, J.; Batakis, O.; Fog, A.

doi:10.1080/02841850312331287709

Cited by 3 publications

(1 citation statement)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Iodixanol has been shown to have a good tolerability and safety profile, particularly for intra-arterial injection. 39 – 42 Similarly, studies comparing intravenous iso-osmolar versus low-osmolar CM found lower incidence of discomfort, better safety and greater enhancement of the hepatic, aorta and portal vein 43 – 45 in patients receiving the iso-osmolar CM. Some clinical studies investigated the possible benefit of iso-osmolar CM in terms of the risk of AKI, with inconsistent results.…”

Section: Reviewmentioning

confidence: 98%

Prevention of post-contrast kidney injury in patients with cancer

Grassedonio,

Incorvaia,

Guarneri

et al. 2024

DIC

View full text Add to dashboard Cite

Post-contrast acute kidney injury is defined as a nephropathy with an increase in serum creatinine of >0.3 mg/dL (or >26.5 μmol/L) or >1.5-times the baseline within 48-72 h of intravascular administration of a contrast medium. Patients with cancer have an increased risk of post-contrast acute kidney injury not only related to the frequent use of contrast medium for computed tomography scans but also to other factors, including the type of tumour, age, oncological therapies, use of other nephrotoxic agents and dehydration. Preventive strategies were developed and may be applied to different risk profiles. Patients at risk may be detected by recently published risk scores.

show abstract

Section: Reviewmentioning

confidence: 98%

Prevention of post-contrast kidney injury in patients with cancer

Grassedonio,

Incorvaia,

Guarneri

et al. 2024

DIC

View full text Add to dashboard Cite

show abstract

Subjective and objective image differences in pediatric computed tomography cardiac angiography using lower iodine concentration

et al. 2017

View full text Add to dashboard Cite

show abstract

Comparison of patient comfort between iodixanol and iopamidol in contrast-enhanced computed tomography of the abdomen and pelvis: a randomized trial

Weiland

Martí‐Bonmatí

Lim³

et al. 2014

Acta Radiol

View full text Add to dashboard Cite

Patients receiving iodixanol had significantly lower moderate-to-severe or severe discomfort than patients receiving iopamidol, with heat being the major contributor. Iodixanol use trended towards better image quality but the difference was not statistically significant. No significant differences in incidences of overall or contrast-related AEs or delayed skin reactions were seen between the two groups. These data support that CM osmolality may be a key determinant of patient discomfort.

show abstract

Pain in femoral arteriography: A double-blind, randomized, clinical study comparing safety and efficacy of the iso-osmolar iodixanol 270mgI/ml and the low-osmolar iomeprol 300 mgI/ml in 9 European centers

Abstract: The IOCM iodixanol caused significantly less frequent injection-associated pain and heat sensation than the LOCM iomeprol during femoral arteriography.

Cited by 3 publications

References 15 publications

Prevention of post-contrast kidney injury in patients with cancer

Prevention of post-contrast kidney injury in patients with cancer

Subjective and objective image differences in pediatric computed tomography cardiac angiography using lower iodine concentration

Comparison of patient comfort between iodixanol and iopamidol in contrast-enhanced computed tomography of the abdomen and pelvis: a randomized trial

Contact Info

Product

Resources

About